A detailed history of Enhancing Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Enhancing Capital LLC holds 8,300 shares of LLY stock, worth $6.04 Million. This represents 3.38% of its overall portfolio holdings.

Number of Shares
8,300
Previous 8,300 -0.0%
Holding current value
$6.04 Million
Previous $2.69 Million 0.74%
% of portfolio
3.38%
Previous 3.21%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $1.87 Million - $2.32 Million
8,300 New
8,300 $2.29 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $691B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Enhancing Capital LLC Portfolio

Follow Enhancing Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enhancing Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Enhancing Capital LLC with notifications on news.